Label Image (Lbl500906231)
Segluromet
Product Images NDC 50090-6231
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Segluromet (NDC 50090-6231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Segluromet 01)
Chemical Structure (Segluromet 02)
Figure 1 (Segluromet 03)
This data provides information on the medication and dosage of Sitagliptin, Metiormin, Glimepiride, Simvastatin, and Ritampin. The table displays results for various measurements including Auc, cmax, and Geometric mean ratio. The values obtained are given in parenthesis along with their percentage relative to ertugiflozin alone. There is also information regarding the dosage and frequency of administration for ertugiflozin.*
Figure 2 (Segluromet 04)
This is a medical report that shows the administration of four different drugs - Sitagliptin, Metformin, Glimepiride, and Simvastatin. The report includes the doses of each drug given in a single dose. Additionally, the report contains a table showing the geometric mean ratio of Auc and Cmax values of Simvastatin Acid administered as Simvastatin relative to concomitant medication alone. There is also mention of the administration of Alertugiflozin at 15mg, given as a single dose.*
Figure 3 (Segluromet 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
